LONN.SW Lonza Group AG
CHF 563.40 -2.39%
Europe · Materials
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-2.39%
YTD
+3.40%
P/E
—
P/B
—
ROE
—
Div yield
—
Beta
0.38
Market cap
—
RSI (14)
49
Next earnings
—
Previous session
close of Oct 8, 2026 · EOD, no live order bookOpen
CHF 570.60
Close
CHF 563.40
VWAP (n/a)
—
Day high
CHF 570.80
Day low
CHF 563.40
Volume
129K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Gene Transfer Technologies Market Size, Share & Trends Analysis to 2036 Featuring Profiles of Thermo Fisher Scientific, Lonza Group, Oxford Biomedica, FUJIFILM Diosynth Biotechnologies, Aldevron and More
Yahoo Finance · Sep 23
Europe Automated and Closed Cell Therapy Processing Systems Market Report (2026-2033) Featuring Profiles of Thermo Fisher Scientific, Cytiva, Sartorius, Miltenyi Biotec B.V. & Co., Lonza Group
Yahoo Finance · Sep 22
Cell Culture Media Market worth $12.9 billion by 2033: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG
Yahoo Finance · Jul 8
[Latest] Global Bioprocess Digital Twin Market Size/Share Worth USD 6.47 Billion by 2035 at a 19.6% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Yahoo Finance · Jun 25
Is Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings?
Yahoo Finance · Apr 23
[Latest] Global Cell Culture Media Bags Market Size/Share Worth USD 2.28 Billion by 2035 at a 5.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Yahoo Finance · Apr 29
Headlines via Yahoo Finance · links open the source · not an endorsement.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell LONN.SW. Try it in the Lab to size a position and see the risk.